Source: TradeTheNews Upside – $VTGN +59.5% (extends the prior-session rally after preliminary PALISADE-4 open-label extension data for fasedienol in social anxiety disorder) – $GRML +24.0% (no clear fresh catalyst identified; exceptionally heavy-volume small-cap move) – $WOR +15.5% (Q1 beat as stronger Building Products results and data-center demand lifted performance) – $TLSI +15.0% (FDA grants 510(k) …
Read in context ›TriSalus Life Sciences Stock (TLSI)
Track TriSalus Life Sciences stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
TLSI
TriSalus Life Sciences
healthcare
At close
$4.34
â–¼ -0.27 (-5.86%)
Sep 25, 4:00 PM ET
After-hours
$4.39
â–² +0.05 (+1.15%)
Sep 25, 7:30 PM ET
Market Cap
$267.23M
P/E Ratio
—
1Y Return
-8.82%
EPS (TTM)
-$1.30
Read the latest TheStreet Pro articles mentioning TriSalus Life Sciences, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning TLSI yet.
Daily Diary Mentions
1 mentionUpside, Downside Movers in the Morning